Viewing StudyNCT00110617



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110617
Status: COMPLETED
Last Update Posted: 2011-05-26
First Post: 2005-05-10

Brief Title: Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Hemolytic Anemia
Sickle Cell Disease
Iron Overload
Keywords:
Name View
Blood Transfusions View
Sickle Cell Disease View
Iron Overload from Repeated Blood Transfusions View
Iron Overload View